Covestro Unveils New Polycarbonate Resin for Safe Administration of Life-Saving Drugs to Patients

Covestro announced a new polycarbonate for medical applications, Makrolon® Rx3440, which offers superior durability and chemical resistance to help prevent cracking so that health care professionals can more safely deliver oncology drugs to patients.

Compared with other transparent resins used for IV access components, comprehensive lab testing has shown that the polycarbonate provides best-in-class chemical and oncology drug resistance. This material also demonstrates the best retention of stress to provide more reliable IV connections.

Makrolon® Rx3440 polycarbonate also offers several other advantages for medical OEMs, including:

• Biocompatible according to ISO 10993-1 and USP Class IV standards

• Greater structural integrity to allow for thin-walled designs

• Toughness to resist mishandling

• Dimensional stability in shipping and storage

"We’ve leveraged our knowledge of this highly regulated market to formulate a material that serves an important need, yet requires minimal validation and requalification by OEMs," said George Paleos, marketing manager for polycarbonate applications in medical and consumer products at Covestro LLC. "Importantly, we’re also able to provide customer support every step of the way from design and material selection to final approval."

For more information about Makrolon® Rx3440 polycarbonate, including testing data, please visit http://www.MakrolonRx3440.com.

In addition, Covestro will exhibit its solutions portfolio for medical applications at its Booth # 2221at the MD&M West Conference and Exposition in Anaheim, CA, Feb. 6-8, 2018.

For more information, please visit www.covestro.com.